T-CELL CLONES OF UNCERTAIN SIGNIFICANCE/ T-CUS

Female patient, 56 years old, with leukocytosis and lymphocytosis and Lymphoma suspicion - Peripheral blood sample with white blood count 23,200 cells / TCD8+ restriction (TCD4/TCD8 ratio 0.1:1). Panel, Immunophenotyping and Gating Strategy. Triage of all the samples was analyzed in the LST tube. The TCRCBeta 1 tube was designed based on EuroFlow’s Orientation Tube for Immunodeficiencies (PIDOT), using CD3, CD4, CD8 and CD45 as “backbones”, CD27 and CD45RA to discriminate T-cell subsets, CD16 and CD56 to exclude NK cells, and including TCRCBeta1 in the PE channel. Results: 59% T Cells: *52.5% TCD8+: 39.4% TD (terminally differentiated) phenotype with increased absolute levels (9,141 cells/μL - normal age range 8-500) CD7dim CD27(-) CD45RA-/+ TCRCBeta1+5% (monoclonal); 0.7% Naive CD45RA+ CD27+ TCRCBeta1+30% (polyclonal), 1.2% CM/TM (central/terminal memory) CD45RA(-) CD27+ TCRCBeta1+19% (polyclonal); 9.7% EM (effector memory) phenotype with increased absolute levels (2,250 cells/μL - normal age range 2-323) CD45RA(-) CD27+ TCRCBeta1+5% (monoclonal). *4.9% TCD4+ TCRCBeta1+44% (polyclonal). Immunophenotype: CD45++ CD3+ CD8+ CD38dim CD45RA-/+ CD45RO-/+ CD2+ CD5++ CD7+FR TCR ALPHA-BETA+ PERFORIN+ TCRCBETA1 ++5%; Negative expression: CD25 CD26 CD27 CD28 TCL1 CCR7 TCR GAMMA-DELTA CD11C CD30 CD16 CD56 CD94. Morphology: In the analyzed smear, 32% of atypical medium-sized lymphoid cells were observed, with a globose nucleus, generally eccentric, with poorly condensed chromatin with an outline of a nucleolus, and a moderately basophilic, polarized and granular cytoplasm. The inicial diagnostic hypothesis was T-Lymphoma, NOS (the authors judged that there were no sufficient NK antigens expressed to characterize T-LGL). However, further investigation showed the patient had no identifiable T Cell lymphoma, and she eventually was diagnosed with Thrombotic Thrombocytopenic Purpura, with classic symptoms and laboratory confirmation. Since the implementation of TRBC1 for detection of abnormal T-cells, persistent clonal expansion of large granular lymphocytes (T-cell clones of uncertain significance/ T-CUS) have been reported in a variety of clinical conditions, such as hematological neoplasms and autoimmunity. The incidence of T-CUS increases with age, and probably represents reactive T-cell small clones (so called immunoclones), with less than 20% of total lymphocytes or 400 cells/mm3, highly prevalent in patients without T-cell malignancy . Most reactive T-CUS cases are CD8+ or CD4+/CD8+ double-positive.

Authors

Institutions

Publication Details

Journal
Hematology Transfusion and Cell Therapy
Published
2025-10-01
DOI
https://doi.org/10.1016/j.htct.2025.103996
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

T-CELL CLONES OF UNCERTAIN SIGNIFICANCE/ T-CUS

Angelika Wagner, Anne Letícia Silva Ferri, Renata da Silva Kalfeltz, Maria Daniela Holthausen Perico et al.
Hematology Transfusion and Cell Therapy
CAR-T cell therapy research
article

T-CELL CLONES OF UNCERTAIN SIGNIFICANCE/ T-CUS

Angelika Wagner, Anne Letícia Silva Ferri, Renata da Silva Kalfeltz, Maria Daniela Holthausen Perico, Franciani Turra Costella Delagnello, Liziani Crestani Bortoluzzi, Paula Gomes Back Prim
article en

Abstract

Female patient, 56 years old, with leukocytosis and lymphocytosis and Lymphoma suspicion - Peripheral blood sample with white blood count 23,200 cells / TCD8+ restriction (TCD4/TCD8 ratio 0.1:1). Panel, Immunophenotyping and Gating Strategy. Triage of all the samples was analyzed in the LST tube. The TCRCBeta 1 tube was designed based on EuroFlow’s Orientation Tube for Immunodeficiencies (PIDOT), using CD3, CD4, CD8 and CD45 as “backbones”, CD27 and CD45RA to discriminate T-cell subsets, CD16 and CD56 to exclude NK cells, and including TCRCBeta1 in the PE channel. Results: 59% T Cells: *52.5% TCD8+: 39.4% TD (terminally differentiated) phenotype with increased absolute levels (9,141 cells/μL - normal age range 8-500) CD7dim CD27(-) CD45RA-/+ TCRCBeta1+5% (monoclonal); 0.7% Naive CD45RA+ CD27+ TCRCBeta1+30% (polyclonal), 1.2% CM/TM (central/terminal memory) CD45RA(-) CD27+ TCRCBeta1+19% (polyclonal); 9.7% EM (effector memory) phenotype with increased absolute levels (2,250 cells/μL - normal age range 2-323) CD45RA(-) CD27+ TCRCBeta1+5% (monoclonal). *4.9% TCD4+ TCRCBeta1+44% (polyclonal). Immunophenotype: CD45++ CD3+ CD8+ CD38dim CD45RA-/+ CD45RO-/+ CD2+ CD5++ CD7+FR TCR ALPHA-BETA+ PERFORIN+ TCRCBETA1 ++5%; Negative expression: CD25 CD26 CD27 CD28 TCL1 CCR7 TCR GAMMA-DELTA CD11C CD30 CD16 CD56 CD94. Morphology: In the analyzed smear, 32% of atypical medium-sized lymphoid cells were observed, with a globose nucleus, generally eccentric, with poorly condensed chromatin with an outline of a nucleolus, and a moderately basophilic, polarized and granular cytoplasm. The inicial diagnostic hypothesis was T-Lymphoma, NOS (the authors judged that there were no sufficient NK antigens expressed to characterize T-LGL). However, further investigation showed the patient had no identifiable T Cell lymphoma, and she eventually was diagnosed with Thrombotic Thrombocytopenic Purpura, with classic symptoms and laboratory confirmation. Since the implementation of TRBC1 for detection of abnormal T-cells, persistent clonal expansion of large granular lymphocytes (T-cell clones of uncertain significance/ T-CUS) have been reported in a variety of clinical conditions, such as hematological neoplasms and autoimmunity. The incidence of T-CUS increases with age, and probably represents reactive T-cell small clones (so called immunoclones), with less than 20% of total lymphocytes or 400 cells/mm3, highly prevalent in patients without T-cell malignancy . Most reactive T-CUS cases are CD8+ or CD4+/CD8+ double-positive.

Hematology Transfusion and Cell TherapyVol. 47
Fundação Centro de Hematologia e Hemoterapia de Minas Gerais (BR)
Openalex Percentile: Top 58%
CAR-T cell therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.